20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Arterial Diseases, Carotid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilar, C; Aragonès, G; Auguet, T; Canela, N; Colom, M; Martín-Paredero, V; Richart, C; Ruyra, X | 1 |
| Akhtar, S; Benter, IF; Canatan, H; Yousif, MH | 1 |
1 trial(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Arterial Diseases, Carotid
| Article | Year |
|---|---|
Targeted metabolomic approach in men with carotid plaque.
Topics: Aged; Carotid Artery Diseases; Endarterectomy, Carotid; Humans; Hydroxyeicosatetraenoic Acids; Male; Mass Spectrometry; Metabolomics; Middle Aged; Plaque, Atherosclerotic | 2018 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Arterial Diseases, Carotid
| Article | Year |
|---|---|
Inhibition of Ca2+/calmodulin-dependent protein kinase II, RAS-GTPase and 20-hydroxyeicosatetraenoic acid attenuates the development of diabetes-induced vascular dysfunction in the rat carotid artery.
Topics: Amidines; Animals; Benzylamines; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Carotid Arteries; Carotid Artery Diseases; Diabetes Mellitus, Experimental; Hydroxyeicosatetraenoic Acids; Monomeric GTP-Binding Proteins; Organophosphonates; Protein Kinase Inhibitors; Rats; Rats, Wistar; Streptozocin; Sulfonamides; Triazoles; Vascular Diseases; Vasoconstriction; Vasodilation | 2005 |